This review describes the current concept of pneumococcal meningitis in cochlear implant recipients based on recent laboratory studies. It examines possible routes of S. pneumoniae infection to the meninges in cochlear implant recipients. It also provides insights into fundamental questions concerning the pathophysiology of pneumococcal meningitis in implant recipients.
implant related meningitis ranged between 13 months and 81 years. The majority ofUS patients were less than 5 years of age; non-US patients were equally distributed amongst adults and children. The onset of meningitis ranged from less than 24 hours to more than 6 years after implantation. More than 60% of US patients developed meningitis within the first year of implantation, many within the first weeks following surgery 1 • Bacteria isolated from CSF specimens were only documented in 69 patients 1
• By far the most common organism identified was Streptococcus pneumoniae (pneumococcus, diplococcus) accounting for 46 cases, or 67% ofthe total. Other bacteria cultured from patients' CSF included Haemophilus influenzae (both types Band non-B) (9 cases); Escherichia coli (4 cases); Streptococcus viridians (3 cases); staphylococcus (4 cases); and non-specific bacteria (4 cases).
However, many of the 118 patients in the FDA report had pre-e~isting risk factors for meningitis before cochlear implantation. These included age (less than 5 years), immunodeficiency, a history of pre-implant meningitis, congenital inner ear deformity, and basilar skull fracture. In addition, the presence of a middle ear infection may predispose patients with an implant to acquire bacterial meningitis: some of the reported cases of meningitis in cochlear implant recipients may have had overt or subclinical otitis media prior to surgery or before the meningitis developed 1
• Therefore, the true aetiology of meningitis in these cochlear implant recipients could not be established from the FDA data.
Pneumococcal meningitis post cochlear implantation Wei eta!.
To investigate the extent ofthe problem, the CDC, the FDA, and state and local health departments in the US conducted a study which focused on young children with cochlear implants, as they constitute the majority of known meningitis cases and represent the population that will receive most cochlear implants in the future 2
• It consisted of a cohort study and a nested case-control investigation of 4,264 children receiving a cochlear implant in the US between January I, 1997 and August 6, 2002 under the age of 6 at the time of implantation. Twenty-nine episodes of bacterial meningitis were reported before September IS, 2002 in 26 children with implants. Nine of the 29 cases occurred within less than a month (peri-operative) of the patient receiving the implant and the remaining 20 occurred I month after implantation. The incidence of all cases of meningitis in the cohort was 239.3 per 100,000 person-years which is significantly higher than the incidence in the age matched cohort of general population of the same time period (2 to S per 100,000 person-years) 2 • Streptococcus pneumoniae was the most common cause of meningitis and accounted for IS of the 24 episodes of bacterial meningitis with a known cause (63% ofthe reported cases).
Four episodes occurred within the first month and II episodes occurred between 1.5 to 19 months post implantation. Three children acquired pneumococcal meningitis despite immunization with 7-valent pneumococcal conjugate vaccine (PCV 7). The serotypes of the bacteria causing the disease were unknown in 2 ofthese children. However, the third child acquired meningitis caused by serotype lOA S. pneumoniae not included in PCV 7. The incidence of post implant meningitis caused by S. pneumoniae was 138. Based on these clinical data, it remains to be determined whether cochlear implantation per se increases the risk of meningitis in subjects with no existing risk factors for acquiring the disease:
The routes of pnemococcal infection
The pathogenesis of pneumococcal meningitis is complex. There may be differences in the pathogenesis of pneumococcal meningitis among subjects with a cochlear implant depending upon the route of bacterial infection. This is because 40% of subjects with post implant meningitis were found to have concurrent acute otitis media and 80% were found to have bacteraemia 2 • Therefore, an understanding of the routes by which S. pneumoniae reaches the meninges is an important first step in examining whether the presence of a cochlear implant in the inner ear increases the risk of pneumococcal meningitis and in determining improved surgical techniques and implant designs in order to reduce the risk. The round window niche can also be another route for otogenic spread of infection from the middle ear to the inner ear. Bacterial toxins, antibiotics, antiseptics, arachidonic acid metabolites, local anesthetics, .
albumin and tracers, when placed in the middle ear transverse the round window membrane 10 • However, the permeability of the round window membrane in humans to S. pneumoniae with and without cochlear implantation is unknown. In animal models, S. pneumoniae were observed to pass through an intact round window membrane ( Figure 2 ) to enter the inner ear and then into the modiolus through the small pores in the osseous spiral laminae 11
• 12
• Grafting the round window membrane with gelatin sponge increases the thickness ofthe membrane and reduces the incidence oflabyrinthitis 12 • Thus, the round window membrane can be a potential site for bacteria to enter the inner ear despite a perfect fibrous seal around the electrode array. However, the thickness of the round window membrane varies across species and is an important factor to consider when designing experiments to study the permeability of the round window membrane to bacteria. The round window membrane in humans is reportedly thicker (40-70flm) than the laboratory animals 13 • On the other hand, in the absence of head trauma, pneumococcal meningitis via bacteraemia, with a subsequent invasion ofthe central nervous system, is thought to be a major route of infection 14
• 15
• This has been supported by animal studies which show a rapid transit of pneumococci via the bloodstream to the brain after the direct inoculation of the bacteria in either the nasopharynx or middle ear cavity 9 • 16 ' 19 • Hence, the role ofhaematogenous spread of the bacteria to the meninges in patients with cochlear implants should be considered when investigating pneumococcal , meningitis post cochlear implantation.
Furthermore, in human cochlear implantation, surgery directly adjacent to the dura within the mastoid or deep to the temporal squamosa in providing a bed for the receiver-stimulator, may affect the blood-brain barrier. Any change may affect both the threshold for direct and haematogenous routes of infection.
Temporal bone studies in patients with pneumococcal meningitis
The routes by which S. pneumoniae reaches the meninges have also been examined in a number of temporal bone studies. Some studies of individual subject's temporal bones with pneumococcal meningitis have provided evidence to support the direct association between otitis media and meningitis and the direct spread of the infection to the meninges via the inner ear In summary, when meningitis occurs in the presence of acute otitis media, there is insufficient evidence to suggest a direct spread of S. pneumoniae from the middle ear to the inner ear then to the meninges as the only means of infection. The role of the haematogenous spread of the bacteria from the middle ear to the meninges should also be considered. Furthermore in patients with meningitis following cochlear, implantation and concurrent acute otitis media, the exact routes by which the bacteria reach the meninges from the middle ear are not known. Therefore, all potential routes of infection should be considered when examining the pathophysiology of pneumococcal meningitis post cochlear implantation.
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Threshold of S. pneumoniae required for meningitis
The occurrence of meningitis seems directly related to the duration and the intensity of the bacteraemia, because these variables determine how many bacteria reach the subarachnoid space 27
• It appears that a threshold ofthe bacteria with the required virulence factors must be reached in the blood and meninges of a healthy animal to establish meningitis, with any breach ofthe dura reducing the threshold of the bacteraemia required to produce meninigitis 28 •
The quantification ofthe bacterial threshold(s) for pneumococcal meningitis is a prerequisite to test whether a cochlear implant increases the risk of meningitis. This was established in an animal model involving the rat 11
• In order to apply the animal research to clinical application, the particular strain of bacteria used in these experimental studies must be able to cause meningitis in both humans and the animal model under study u. Furthermore, the routes by which the pneumococci reach the CNS in the animal model must also resemble human infection. These two important criteria were achieved by using
Streptococcus pneumoniae 447A, which carries the type 2 capsular antigen u. In the presence of a cochlear implant, the bacteria can reach the CNS from the upper respiratory tract mucosa either through the systemic circulation or via the inner ear. The bacteria can also reach the CNS via a combination of both routes. Three different methods of inoculation (haematogenous, middle ear and inner ear) were implemented in the laboratory study to cover all potential routes of infection u.
In the absence of a cochlear implant, the quantitative thre~hold model demonstrated that a minimal threshold of bacterial count was required to induce meningitis in healthy non-implanted animals ( Figure 3 
Effects of inner trauma on the risk of pneumococcal meningitis
In addition to the presence of a cochlear implant, a severe surgical insertion trauma (fracture of osseous spiral laminae and modiolus) was found to be an independent factor for subsequent risk of pneumococcal meningitis 35 • In these instances, the threshold for infection was reduced when bacteria were given via the middle or inner ear route but not the haematogenous route 35 • Presumably, a more direct communication between the inner ear and the internal auditory meatus (lAM) was created by trauma to the modiolus and OSL. This provided an easier access route for the bacteria to reach the CNS once in the inner ear. As local inner ear trauma did not alter the haematogenous route of infection, one would expect the risk of pneumococcal meningitis to be unaltered when the bacteria were inoculated via the haematogenous routes 
Histopathology and routes of infection based on the threshold model
The histopathological appearance ofthe cochlear specimens was very distinct and varied between different routes of inoculation 11 • 29 • 32
• Animals that acquired meningitis following haematogenous inoculation showed a bilateral symmetrical distribution of bacteria and inflammatory cells within the cochleae ( Figure   5 )
• In these animals, bacteria were found predominately in the modiolus and lAM during the early stage of meningitis and they were not observed in the scalae of the ipsilateral and contralateral cochlea. In contrast, in meningitic rats that received either a middle ear or inner ear inoculation, an asymmetrical distribution of bacteria and inflammatory cells was seen ( Figure 6 ). In these instances, a severe labyrinthitis was observed in the ipsilateral ear compared to the contralateral ear 11 ' 29 • 32
• Bacterial organisms and inflammatory cells were found in all three scalae of the ipsilateral ear predominately in both the scala tympani and scala vestibuli. In the contralateral ear, bacteria and inflammatory cells were predominately located in the basal tum of the scala tympani. The histopathological appearances of the the ipsilateral and contralateral cochleae during early stage of meningitis can be used to determine the route ofinfection from the upper respiratory tract mucosa to the central nervous system.
As noted above, Streptococcus pneumoniae were found to enter the pores within the osseous spiral laminae and track along the peri-vascular and peri-neural space within the modiolus to reach the internal acoustic meatus and central nervous system There is a great variation in published descriptionsofthe patency, shape and size of the human cochlear aqueduct 43
• 44
• Some studies described patency of the cochlear aqueduct to be age dependent 45 • 46 ; in newborns it is reportedly short and patent
43
• However, another study found no statistical correlation between age and patency of the cochlear aqueduct 44
• To date little is known about the patency and size of aqueduct in patients with cochlear malformation.
Conclusion:
The most common organism identified in post implantation meningitis isS. pneumoniae. 26.
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